Pliant Therapeutics【PLRX】銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

1.58

買値

1.57

売値

1.58

出来高

128,792

0.00 日の範囲 0.00

1.26 52 週間の範囲 16.52

時価総額

96.149M

前日終値

1.43

始値

時刻

100

1.58

(formt)

最終取引時間

20:53:57

財務取引量

VWAP

平均取引量 (3 か月)

2,516,360

発行済株式数

60,853,623

配当利回り

PER

-0.54

1 株当たり利益 (EPS)

-2.65

歳入

1.58M

純利益

-161.34M

Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis. Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis.

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

pliantrx.com.

本社

Dover, Delaware, USA

設立

Pliant Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker PLRX. The last closing price for Pliant Therapeutics was US$1.43. Over the last year, Pliant Therapeutics shares have traded in a share price range of US$ 1.26 to US$ 16.52.

Pliant Therapeutics currently has 60,853,623 shares in issue. The market capitalisation of Pliant Therapeutics is US$87.02 million. Pliant Therapeutics has a price to earnings ratio (PE ratio) of -0.54.

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2024 Financial Results

Discontinuation of BEACON-IPF following DSMB and outside expert panel recommendation SOUTH SAN FRANCISCO...

Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis

SOUTH SAN FRANCISCO, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX...

Form 8-K - Current report

Pliant Therapeutics Announces Next Steps Following DSMB Recommendation on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis

SOUTH SAN FRANCISCO, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.14	9.72222222222	1.44	1.79	1.26	4284440	1.46475523	CS
4	-1.45	-47.8547854785	3.03	3.78	1.26	4829774	2.35146955	CS
12	-12.2	-88.534107402	13.78	15	1.26	2516360	4.03690824	CS
26	-11.44	-87.8648233487	13.02	16.1	1.26	1361260	5.78087026	CS
52	-14.05	-89.8912348049	15.63	16.52	1.26	903535	7.6117302	CS
156	-7.32	-82.2471910112	8.9	36.64	1.26	800616	15.93455517	CS
260	-20.92	-92.9777777778	22.5	43.92	1.26	550764	16.68736317	CS

PLRX - Frequently Asked Questions (FAQ)

What is the current Pliant Therapeutics share price?

The current share price of Pliant Therapeutics is US$ 1.58

How many Pliant Therapeutics shares are in issue?

Pliant Therapeutics has 60,853,623 shares in issue

What is the market cap of Pliant Therapeutics?

The market capitalisation of Pliant Therapeutics is USD 87.02M

What is the 1 year trading range for Pliant Therapeutics share price?

Pliant Therapeutics has traded in the range of US$ 1.26 to US$ 16.52 during the past year

What is the PE ratio of Pliant Therapeutics?

The price to earnings ratio of Pliant Therapeutics is -0.54

What is the cash to sales ratio of Pliant Therapeutics?

The cash to sales ratio of Pliant Therapeutics is 55

What is the reporting currency for Pliant Therapeutics?

Pliant Therapeutics reports financial results in USD

What is the latest annual turnover for Pliant Therapeutics?

The latest annual turnover of Pliant Therapeutics is USD 1.58M

What is the latest annual profit for Pliant Therapeutics?

The latest annual profit of Pliant Therapeutics is USD -161.34M

What is the registered address of Pliant Therapeutics?

The registered address for Pliant Therapeutics is 850 NEW BURTON ROAD SUITE 201, DOVER, DELAWARE, 19904

What is the Pliant Therapeutics website address?

The website address for Pliant Therapeutics is pliantrx.com.

Which industry sector does Pliant Therapeutics operate in?

Pliant Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
AWHAspira Womans Health Inc	US$ 0.3716 (87.68%)	76.99M
TSVT2seventy bio Inc	US$ 4.925 (75.89%)	1.12M
CUTRCutera Inc	US$ 0.1924 (49.73%)	33.94M
SNOASonoma Pharmaceuticals Inc	US$ 4.09 (46.59%)	17.33M
TNONTenon Medical Inc	US$ 1.78 (42.40%)	12.25M
MBXMBX Biosciences Inc	US$ 5.01 (-44.21%)	2
ARVNArvinas Inc	US$ 10.85 (-38.21%)	263.44k
JANXJanux Therapeutics Inc	US$ 20.05 (-33.65%)	40
SVRASavara Inc	US$ 2.01 (-24.44%)	4
SNCRSynchronoss Technologies Inc	US$ 6.01 (-22.45%)	4
AWHAspira Womans Health Inc	US$ 0.3716 (87.68%)	76.99M
CUTRCutera Inc	US$ 0.1924 (49.73%)	33.94M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 7.77 (5.28%)	22.95M
SNOASonoma Pharmaceuticals Inc	US$ 4.09 (46.59%)	17.33M
BTOGBit Origin Ltd	US$ 0.4837 (1.81%)	15.09M